Liu, J.;                     Rajasekaran, N.;                     Hossain, A.;                     Zhang, C.;                     Guo, S.;                     Kang, B.;                     Jung, H.;                     Kim, H.;                     Wang, G.    
        Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies. Pharmaceuticals 2021, 14, 719.
    https://doi.org/10.3390/ph14080719
    AMA Style
    
                                Liu J,                                 Rajasekaran N,                                 Hossain A,                                 Zhang C,                                 Guo S,                                 Kang B,                                 Jung H,                                 Kim H,                                 Wang G.        
                Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies. Pharmaceuticals. 2021; 14(8):719.
        https://doi.org/10.3390/ph14080719
    
    Chicago/Turabian Style
    
                                Liu, Jiawang,                                 Nirmal Rajasekaran,                                 Ahamed Hossain,                                 Changde Zhang,                                 Shanchun Guo,                                 Borui Kang,                                 Hunsoon Jung,                                 Hongjoong Kim,                                 and Guangdi Wang.        
                2021. "Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies" Pharmaceuticals 14, no. 8: 719.
        https://doi.org/10.3390/ph14080719
    
    APA Style
    
                                Liu, J.,                                 Rajasekaran, N.,                                 Hossain, A.,                                 Zhang, C.,                                 Guo, S.,                                 Kang, B.,                                 Jung, H.,                                 Kim, H.,                                 & Wang, G.        
        
        (2021). Fulvestrant-3-Boronic Acid (ZB716) Demonstrates Oral Bioavailability and Favorable Pharmacokinetic Profile in Preclinical ADME Studies. Pharmaceuticals, 14(8), 719.
        https://doi.org/10.3390/ph14080719